Researchers identify biomarkers for checkpoint inhibitor-induced hyperprogression of melanoma cells November 22, 2022 | …
Duke Cancer Institute researchers have identified potential biomarkers that predict the likelihood for checkpoint inhibitor drugs to backfire, driving hyper-progression of melanoma cells instead of unleashing the immune system to…